Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods. (TOH-HTIC)
Acute or chronic liver failure (fulminant hepatitis or advanced cirrhosis) disrupts brain physiology. Beyond classical hepatic encephalopathy, intracranial hypertension may occur.During liver transplantation (LT) surgery, many factors can lead to cerebral assault. In addition, intracranial hypertension measured with invasive methods has been described in certain phases of LT, especially at the time of reperfusion.
The invasive monitoring of the intracranial pressure is not used in these patients, due to a high risk of infection and bleeding. The non-invasive monitoring of intracranial pressure has been widely developed in recent years : transcranial doppler and recently ultrasound of the optic nerve sheath (ONSD) allow an effective detection of intracranial hypertension.
Studieoversigt
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Lyon, Frankrig, 69004
- Département d'anesthésie réanimation
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients ≥ 18 years
- Patients who underwent orthotopic liver transplantation
- Patients who have received clear information and not opposed to participate in the study
- Patients affiliated to a social security scheme or similar
- Patients not undergoing a measure of legal protection
Exclusion Criteria:
- Opposition to participation in the study
- Patients < 18 years
- Pregnant women or breastfeeding
- Deprived of individual liberty
- Non-affiliated to a social security scheme
- Known ophthalmic pathology: untreated cataracts, glaucoma
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Patients undergoing liver transplantation
|
Ultrasound measurements of the optic nerve sheath diameter and intracranial Doppler, at 4 time points during surgery (incision, anhepatic phase + 30 min, declamping + 5 min, declamping + 30 min), and at day 1 and day 5 after surgery, to detect presence of intracranial hypertension. Search of any neurological complication during the 5 postoperative days. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Measure of the optic nerve sheath diameter during surgery.
Tidsramme: at incision
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at incision
|
|
Measure of the optic nerve sheath diameter during surgery.
Tidsramme: at anhepatic phase + 30 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at anhepatic phase + 30 min
|
|
Measure of the optic nerve sheath diameter during surgery.
Tidsramme: at declamping + 5 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at declamping + 5 min
|
|
Measure of the optic nerve sheath diameter during surgery.
Tidsramme: at declamping + 30 min
|
A value of the optic nerve sheath diameter (averaged over 2 measures) greater than 5.7 mm will be considered pathological, indicating the strong likelihood of intracranial hypertension (PPV near 100% for an intracranial pressure > 25 cmh2o in the literature) The optic nerve sheath diameter will be measured by ultrasonography, in accordance with existing protocols: Use probe 7.5 Mhz in 2D mode, patient supine dorsi, implementation of ultrasound gel on the closed eyelid, search for the optimal window 3mm, optic nerve sheath diameter measurement behind the retina using an electronic cursor along an axis perpendicular to the optic nerve. 2 measurements per side (sagittal and transverse plane) averaged.
Values> 5.7mm are deemed pathological.
|
at declamping + 30 min
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Tidsramme: at incision
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at incision
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Tidsramme: at anhepatic phase + 30 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at anhepatic phase + 30 min
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Tidsramme: at declamping + 5 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at declamping + 5 min
|
|
Measurement of intracranial hypertension with transcranial Doppler during surgery.
Tidsramme: at declamping + 30 min
|
Diastolic velocity value of less than 20 cm s-1 and a pulsatility index greater than 1.4 will be considered pathological, indicating a high probability of intracranial hypertension. The transcranial Doppler measurements are performed according to the existing protocols: use of a cardiac probe 2 Mhz, positioned temporal window, the circle of Willis color Doppler tracking then collecting the Doppler signal of the middle cerebral artery in Doppler pulsed with the insonation angle as small as possible to a depth between 40 and 60 mm. Measuring systolic, diastolic and mean velocity )Vs, Vd, Vm) and calculating the pulsatility Index (PI) bilaterally. PI values of> 1.4 and Vd <20 cm s-1 will be considered pathological. |
at declamping + 30 min
|
|
Measurement of intracranial hypertension with transcranial Doppler
Tidsramme: at 1 day after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 1 day after surgery.
|
|
Measure of the optic nerve sheath diameter after surgery.
Tidsramme: at 1 day after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 1 day after surgery.
|
|
Measurement of intracranial hypertension with transcranial Doppler
Tidsramme: at 5 days after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 5 days after surgery.
|
|
Measure of the optic nerve sheath diameter after surgery.
Tidsramme: at 5 days after surgery.
|
we use the same methods and the same thresholds as those used during surgery (primary outcome measure, and measure1 of secondary outcome measure)
|
at 5 days after surgery.
|
|
The early appearance of neurological complications after surgery.
Tidsramme: During the 5 days following surgery
|
A monitoring with simultaneous collection of clinical, biological and ultrasound parameters, will be done.
Neurological complications after surgery will be defined by the presence of at least one of the following criteria: Glasgow score < 14 in a non-sedated patient, behavioral disorders, agitation (evaluation according to the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score), epilepsy, imaging or MRI scan.
Pathological evolved compared to the preoperative including hemorrhagic or thrombotic cardiovascular event.
Various confounding factors will be considered (serum sodium, serum tacrolimus, serum magnesium, ammonia, sedatives).
|
During the 5 days following surgery
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Mathieu GAZON, MD, Hospices Civils de Lyon
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 69HCL15_0483
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Levertransplantation
-
L'OrealRekrutteringPigmentering fra det virkelige livIndien
-
Universidad Complutense de MadridRekruttering
-
Sisli Hamidiye Etfal Training and Research HospitalIkke rekrutterer endnu
-
Bournemouth UniversityDorset County Hospital NHS Foundation TrustAfsluttetErfaring, livDet Forenede Kongerige
-
Swiss Federal Institute of TechnologyAfsluttetÆldret | Uafhængigt livSchweiz
-
University of California, Los AngelesVA Greater Los Angeles Healthcare SystemTrukket tilbageVeteranfamilier | Familiekommunikation | Civilt liv reintegrationForenede Stater
-
Diakonie Kliniken ZschadraßChemnitz University of TechnologyAfsluttetMantra meditation | Mantra Meditation + Kropsorienteret Yoga | Mantra Meditation + Etisk Liv | Mantra Meditation + Kropsorienteret Yoga + Etisk LivTyskland
-
Atılım UniversityIkke rekrutterer endnuDOBBELT OPGAVE | DEGLUTİTİON | KOGNITIV FUNKTION | AKTIVITETER I DAGLIGT LIV
-
Universitätsklinikum Hamburg-EppendorfGerman Research FoundationRekrutteringForventningseffekter på følelsesmæssig behandling i det sene livTyskland
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergAfsluttetUafhængigt liv | Gamle og meget gamle mennesker | FungererTyskland
Kliniske forsøg med Ultrasound
-
ReCor Medical, Inc.Ikke rekrutterer endnuHjerte-kar-sygdomme | Karsygdomme | Forhøjet blodtryk
-
ReCor Medical, Inc.RekrutteringForhøjet blodtrykTyskland, Holland, Belgien, Frankrig, Monaco, Schweiz, Det Forenede Kongerige
-
Medical University of South CarolinaSouth Carolina Spinal Cord Injury Research FundRekrutteringRygmarvssygdomme | Spinal stenose | Rygmarvsskader | Degeneration af rygsøjlen | Rygmarvskompression | Rygsøjle sygdom | RygmarvsskadeForenede Stater
-
Dr. Linda McLeanOttawa Hospital Research Institute; The Ottawa HospitalTilmelding efter invitation
-
The University of Hong KongAfsluttet
-
The Hospital for Sick ChildrenSunnybrook Health Sciences CentreAfsluttetSmerte | Osteoid Osteom | Godartet knogletumorCanada
-
The University of Hong KongSuspenderetPapillar Thyroid MicrocarcinomHong Kong
-
Fundacion para la Investigacion y Formacion en...AfsluttetULTRASONOGRAFI | PRIMÆRE SUNDHEDSSEKTORSpanien
-
Hospices Civils de LyonAfsluttet